SQZ Biotechnologies Company
News
SQZ Biotechnologies to be delisted from the NYSE
SeekingAlpha.com: All News The New York Stock Exchange has begun proceedings to delist SQZ Biotechnologies (SQZ) common stock. Read more here.\n more…
Head to Head Contrast: SQZ Biotechnologies (NYSE:SQZ) & Beam Therapeutics (NASDAQ:BEAM)
Ticker Report SQZ Biotechnologies (NYSE:SQZ Free Report) and Beam Therapeutics (NASDAQ:BEAM Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ...\n more…
SQZ Biotechnologies (NYSE:SQZ) Shares Set to Reverse Split on Friday, July 7th
Zolmax Shares of SQZ Biotechnologies (NYSE:SQZ Free Report) are set to reverse split before the market opens on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, July 7th. SQZ ...\n more…
SQZ Biotechnologies (NYSE:SQZ) Shares Scheduled to Reverse Split on Friday, July 7th
Ticker Report SQZ Biotechnologies (NYSE:SQZ Get Rating) shares are scheduled to reverse split on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, July 7th. SQZ Biotechnologies Stock ...\n more…
SQZ Biotechnologies to effect 1-for-10 reverse stock split
SeekingAlpha.com: All News Company Received Notice Regarding NYSE Continued Listing Standards Section 802.01B SQZ Biotechnologies (SQZ) has approved a 1-for-10 reverse stock split of its common stock, effective...\n more…
SQZ Biotechnologies (NYSE:SQZ) & Innate Pharma (NASDAQ:IPHA) Head to Head Comparison
Ticker Report Innate Pharma (NASDAQ:IPHA Get Rating) and SQZ Biotechnologies (NYSE:SQZ Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, ...\n more…